XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Equity - USD ($)
shares in Millions, $ in Millions
Total
Ordinary Shares [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Shares [Member]
Total Teva Shareholders' Equity [Member]
Non-controlling Interests [Member]
Beginning balance at Dec. 31, 2018 $ 15,794 $ 56 $ 27,210 $ (5,958) $ (2,459) $ (4,142) $ 14,707 $ 1,087
Beginning balance, shares at Dec. 31, 2018   1,196            
Net Income (loss) (768)     (794)     (794) 26
Other Comprehensive income (loss) 170       147   147 23
Issuance of shares, value [1]            
Issuance of shares, shares   2            
Issuance of Treasury Shares 6   (8)     14 6  
Stock-based compensation expense 64   64       64  
Transactions with non-controlling interests (8)             (8)
Other (8)   (8)       (8)  
Ending balance at Jun. 30, 2019 15,251 $ 56 27,258 (6,752) (2,312) (4,128) 14,122 1,128
Ending balance, shares at Jun. 30, 2019   1,198            
Beginning balance at Mar. 31, 2019 15,821 $ 56 27,234 (6,063) (2,359) (4,137) 14,732 1,089
Beginning balance, shares at Mar. 31, 2019   1,198            
Net Income (loss) (671)     (689)     (689) 18
Other Comprehensive income (loss) 76       47   47 29
Issuance of shares, value [1]            
Issuance of Treasury Shares 3   (6)     9 3  
Stock-based compensation expense 32   32       32  
Transactions with non-controlling interests (8)             (8)
Other (2)   (2)       (2)  
Ending balance at Jun. 30, 2019 15,251 $ 56 27,258 (6,752) (2,312) (4,128) 14,122 1,128
Ending balance, shares at Jun. 30, 2019   1,198            
Beginning balance at Dec. 31, 2019 15,063 $ 56 27,312 (6,956) (2,312) (4,128) 13,972 1,091
Beginning balance, shares at Dec. 31, 2019   1,198            
Net Income (loss) 78     209     209 (131)
Other Comprehensive income (loss) (379)       (391)   (391) 12
Issuance of shares, value          
Issuance of shares, shares   4            
Stock-based compensation expense 62   62       62  
Ending balance at Jun. 30, 2020 14,824 $ 57 27,374 (6,747) (2,703) (4,128) 13,852 972
Ending balance, shares at Jun. 30, 2020   1,202            
Beginning balance at Mar. 31, 2020 14,588 $ 56 27,342 (6,887) (2,852) (4,128) 13,531 1,057
Beginning balance, shares at Mar. 31, 2020   1,201            
Net Income (loss) 53     140     140 (87)
Other Comprehensive income (loss) 151       149   149 2
Issuance of shares, value          
Issuance of shares, shares   1            
Stock-based compensation expense 32   32       32  
Ending balance at Jun. 30, 2020 $ 14,824 $ 57 $ 27,374 $ (6,747) $ (2,703) $ (4,128) $ 13,852 $ 972
Ending balance, shares at Jun. 30, 2020   1,202            
[1] Represents an amount less than 0.5 million.